Year: 2023
Reference No.: IB No. 2023-162
Category: Summary of Awarded Contract
Approved Budget for the Contract: 870,000,000.00
Awardee/Supplier: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Date of NOA: Tuesday, July 4, 2023
PO/Contract No.: GOP-C-2023-115
Effectivity and Expiration Date of Contract: Friday, July 21, 2023 to Thursday, October 19, 2023
NTP Contract Date: Thursday, July 20, 2023
Contract Period: 1st Tranche = 750,000 doses for 60 cd upon receipt of approved NTP and 2nd Tranche = 750,000 doses for 90 cd upon receipt of approved NTP
Name of Winning Bidder: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Official Business Address: KM.14 West Service Rd. SSH cor. Edison Ave., Brgy. Sun Valley, Paranaque City
Amount of Contract Awarded: 870,000,000.00
Date of Award: Tuesday, July 4, 2023
Date of Acceptance: Tuesday, July 4, 2023
Implementing Office/End-User Unit/s: Disease Prevention and Control Bureau
Date Posted: July 25, 2023